No photo of Jim Neaton
Contact Expert

View Scopus Profile

Jim Neaton

1973 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Extended follow-up of randomized participants in the INSIGHT START trial

Neaton, J.

NIH Nat'l Inst of Allergy & Infect Dis

5/17/19 → 4/30/24

Project: Research project

PALM

Neaton, J.

Leidos Biomedical Research, Inc.

11/21/18 → 9/30/20

Project: Research project

MASTER: RFP S18-107 Expert Emergency Clinical Research Response

Neaton, J.

Leidos Biomedical Research, Inc.

10/5/18 → 6/30/23

Project: Research project

    • HIV Biomarker Testing

    Neaton, J.

    Leidos Biomedical Research, Inc.

    4/9/18 → 6/30/20

    Project: Research project

    • PREVAIL VI: Identification of Host Genetic Factors Under

    Neaton, J. & Reilly, C. S.

    Leidos Biomedical Research, Inc.

    3/1/18 → 9/25/21

    Project: Research project

    • Research Output

    Role of inflammatory biomarkers in the prevalence and incidence of hypertension among HIV-positive participants in the START trial

    Ghazi, L., Baker, J. V., Sharma, S., Jain, M. K., Palfreeman, A., Necsoi, C., Murray, D. D., Neaton, J. D. & Drawz, P. E., Jan 1 2020, In : American journal of hypertension. 33, 1, p. 43-52 10 p.

    Research output: Contribution to journal › Article

    • A longitudinal study of Ebola sequelae in Liberia

    PREVAIL III Study Group, Mar 7 2019, In : New England Journal of Medicine. 380, 10, p. 924-934 11 p.

    Research output: Contribution to journal › Article

    • 13 Scopus citations

    Association between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants from the Strategic Timing of AntiRetroviral Treatment Trial

    Ekenberg, C., Tang, M. H., Zucco, A. G., Murray, D. D., Macpherson, C. R., Hu, X., Sherman, B. T., Losso, M. H., Wood, R., Paredes, R., Molina, J. M., Helleberg, M., Jina, N., Kityo, C. M., Florence, E., Polizzotto, M. N., Neaton, J. D., Lane, H. C. & Lundgren, J. D., Sep 13 2019, In : Journal of Infectious Diseases. 220, 8, p. 1325-1334 10 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Association of Rivaroxaban with Thromboembolic Events in Patients with Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial

    Greenberg, B., Neaton, J., Anker, S. D., Byra, W. M., Cleland, J. G. F., Deng, H., Fu, M., La Police, D. A., Lam, C. S. P., Mehra, M. R., Nessel, C. C., Spiro, T. E., Van Veldhuisen, D. J., Vanden Boom, C. M. & Zannad, F., Jun 2019, In : JAMA cardiology. 4, 6, p. 515-523 9 p.

    Research output: Contribution to journal › Article

    • 13 Scopus citations

    A win ratio approach to the re-analysis of Multiple Risk Factor Intervention Trial

    Kotalik, A., Eaton, A., Lian, Q., Serrano, C., Connett, J. & Neaton, J. D., Dec 1 2019, In : Clinical Trials. 16, 6, p. 626-634 9 p.

    Research output: Contribution to journal › Article